Quarterly Transactions Made in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). The information is specifically focused on institutions that hold shares of BIOCRYST PHARMACEUTICALS INC.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 7,132,105 | 4,267,590 | 11,399,695 | 7,992,731 | 1,658,191 | 9,650,922 | 1,748,773 | |
| Q4 2021 | 15,164,134 | 10,143,895 | 25,308,029 | 7,915,589 | 1,711,495 | 9,627,084 | 15,680,945 | |
| Q1 2022 | 16,193,081 | 10,702,423 | 26,895,504 | 18,946,778 | 2,905,511 | 21,852,289 | 5,043,215 | |
| Q2 2022 | 29,101,480 | 18,084,526 | 47,186,006 | 8,965,219 | 9,804,356 | 18,769,575 | 28,416,431 | |
| Q3 2022 | 8,740,919 | 6,829,407 | 15,570,326 | 12,382,029 | 71,081 | 12,453,110 | 3,117,216 | |
| Q4 2022 | 15,191,637 | 9,846,770 | 25,038,407 | 10,210,149 | 29,226 | 10,239,375 | 14,799,032 | |
| Q1 2023 | 32,503,916 | 10,711,143 | 43,215,059 | 18,256,661 | 145,921 | 18,402,582 | 24,812,477 | |
| Q2 2023 | 20,976,481 | 3,207,562 | 24,184,043 | 13,709,165 | 1,985,365 | 15,694,530 | 8,489,513 | |
| Q3 2023 | 15,256,817 | 6,455,597 | 21,712,414 | 11,522,572 | 1,073,216 | 12,595,788 | 9,116,626 | |
| Q4 2023 | 26,682,290 | 6,109,291 | 32,791,581 | 19,910,884 | 0 | 19,910,884 | 12,880,697 | |
| Q1 2024 | 18,322,586 | 2,952,835 | 21,275,421 | 14,234,491 | 0 | 14,234,491 | 7,040,930 | |
| Q2 2024 | 24,622,037 | 3,999,336 | 28,621,373 | 30,536,198 | 1,300 | 30,537,498 | -1,916,125 | |
| Q3 2024 | 8,722,987 | 4,733,586 | 13,456,573 | 8,679,633 | 0 | 8,679,633 | 4,776,940 | |